Show simple item record

Rapid reduction of central line infections in hospitalized pediatric oncology patients through simple quality improvement methods

dc.contributor.authorChoi, Sung W.en_US
dc.contributor.authorChang, Lawrenceen_US
dc.contributor.authorHanauer, David A.en_US
dc.contributor.authorShaffer‐hartman, Jacquelineen_US
dc.contributor.authorTeitelbaum, Danielen_US
dc.contributor.authorLewis, Ianen_US
dc.contributor.authorBlackwood, Alexen_US
dc.contributor.authorAkcasu, Nuren_US
dc.contributor.authorSteel, Janellen_US
dc.contributor.authorChristensen, Joyen_US
dc.contributor.authorNiedner, Matthew F.en_US
dc.date.accessioned2013-01-03T19:41:13Z
dc.date.available2014-04-02T15:08:07Zen_US
dc.date.issued2013-02en_US
dc.identifier.citationChoi, Sung W.; Chang, Lawrence; Hanauer, David A.; Shaffer‐hartman, Jacqueline ; Teitelbaum, Daniel; Lewis, Ian; Blackwood, Alex; Akcasu, Nur; Steel, Janell; Christensen, Joy; Niedner, Matthew F. (2013). "Rapid reduction of central line infections in hospitalized pediatric oncology patients through simple quality improvement methods ." Pediatric Blood & Cancer 60(2): 262-269. <http://hdl.handle.net/2027.42/95163>en_US
dc.identifier.issn1545-5009en_US
dc.identifier.issn1545-5017en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/95163
dc.description.abstractBackground Pediatric hematology–oncology (PHO) patients are at significant risk for developing central line‐associated bloodstream infections (CLA‐BSIs) due to their prolonged dependence on such catheters. Effective strategies to eliminate these preventable infections are urgently needed. In this study, we investigated the implementation of bundled central line maintenance practices and their effect on hospital‐acquired CLA‐BSIs. Materials and Methods CLA‐BSI rates were analyzed within a single‐institution's PHO unit between January 2005 and June 2011. In May 2008, a multidisciplinary quality improvement team developed techniques to improve the PHO unit's safety culture and implemented the use of catheter maintenance practices tailored to PHO patients. Data analysis was performed using time‐series methods to evaluate the pre‐ and post‐intervention effect of the practice changes. Results The pre‐intervention CLA‐BSI incidence was 2.92 per 1,000‐patient days (PD) and coagulase‐negative Staphylococcus was the most prevalent pathogen (29%). In the post‐intervention period, the CLA‐BSI rate decreased substantially (45%) to 1.61 per 1,000‐PD ( P  < 0.004). Early on, blood and marrow transplant (BMT) patients had a threefold higher CLA‐BSI rate compared to non‐BMT patients ( P  < 0.033). With additional infection control countermeasures added to the bundled practices, BMT patients experienced a larger CLA‐BSI rate reduction such that BMT and non‐BMT CLA‐BSI rates were not significantly different post‐intervention. Conclusions By adopting and effectively implementing uniform maintenance catheter care practices, learning multidisciplinary teamwork, and promoting a culture of patient safety, the CLA‐BSI incidence in our study population was significantly reduced and maintained. Pediatr Blood Cancer 2013;60:262–269. © 2012 Wiley Periodicals, Inc.en_US
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherPediatric Hematology Oncologyen_US
dc.subject.otherBlood and Marrow Transplanten_US
dc.subject.otherBlood Stream Infectionsen_US
dc.subject.otherCentral Line‐Associated Bloodstream Infectionen_US
dc.subject.otherChildrenen_US
dc.subject.otherHospital Acquired Infectionsen_US
dc.subject.otherInfection Controlen_US
dc.subject.otherQuality Improvementen_US
dc.subject.otherCLA‐BSIen_US
dc.titleRapid reduction of central line infections in hospitalized pediatric oncology patients through simple quality improvement methodsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPediatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumBlood and Marrow Transplant Program, University of Michigan, 1500 E. Medical Center Drive, 5303 Cancer Center, Ann Arbor, MI 48109‐5942.en_US
dc.contributor.affiliationumDivision of Pediatric Critical Care, Department of Pediatrics, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDivision of Pediatric Anesthesiology, Department of Anesthesiology, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDivision of Pediatric Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Infection Control, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumGeneral Pediatrics and Informatics Core of the Comprehensive Cancer Center, Department of Pediatrics, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumPediatric Hematology–Oncology, Department of Pediatrics, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Nursing, University of Michigan, Ann Arbor, Michiganen_US
dc.identifier.pmid22522576en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/95163/1/24187_ftp.pdf
dc.identifier.doi10.1002/pbc.24187en_US
dc.identifier.sourcePediatric Blood & Canceren_US
dc.identifier.citedreferenceMcLean TW, Fisher CJ, Snively BM, et al. Central venous lines in children with lesser risk acute lymphoblastic leukemia: Optimal type and timing of placement. J Clin Oncol 2005; 23: 3024 – 3029.en_US
dc.identifier.citedreferencePronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter‐related bloodstream infections in the ICU. N Engl J Med 2006; 355: 2725 – 2732.en_US
dc.identifier.citedreferencePronovost PJ, Goeschel CA, Colantuoni E, et al. Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: Observational study. BMJ 2010; 340: c309.en_US
dc.identifier.citedreferencePronovost PJ, Berenholtz SM, Goeschel CA, et al. Creating high reliability in health care organizations. Health Serv Res 2006; 41: 1599 – 1617.en_US
dc.identifier.citedreferenceInstitute of Medicine. To Err is Human: Building a Safer Health System. 1999. http://www.iom.edu/Reports/1999/To‐Err‐is‐Human‐Building‐A‐Safer‐Health‐System.aspx. Accessed on February 28, 2012.en_US
dc.identifier.citedreferenceInstitute of Medicine. Rewarding Provider Performance: Aligning Incentives in Medicare. 2006. http://iom.edu/Reports/2006/Rewarding‐Provider‐Performance‐Aligning‐Incentives‐in‐Medicare.aspx. Accessed on February 28, 2012.en_US
dc.identifier.citedreferenceLindenauer PK, Remus D, Roman S, et al. Public reporting and pay for performance in hospital quality improvement. N Engl J Med 2007; 356: 486 – 496.en_US
dc.identifier.citedreferenceMurray LJ, Lee R, Martens C. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp‐Ipr/Ipr mouse. Eur J Immunol 1990; 20: 163 – 170.en_US
dc.identifier.citedreferenceIscove NN, Sieber F. Erythroid progenitors in mouse bone marrow detected by macroscopic colony formation in culture. Exp Haematol 1975; 3: 32 – 43.en_US
dc.identifier.citedreferenceCostello JM, Morrow DF, Graham DA, et al. Systematic intervention to reduce central line‐associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics 2008; 121: 915 – 923.en_US
dc.identifier.citedreferenceMiller MR, Griswold M, Harris JM II, et al. Decreasing PICU catheter‐associated bloodstream infections: NACHRI's quality transformation efforts. Pediatrics 2010; 125: 206 – 213.en_US
dc.identifier.citedreferenceChuengchitraks S, Sirithangkul S, Staworn D, et al. Impact of new practice guideline to prevent catheter‐related blood stream infection (CRBSI): Experience at the Pediatric Intensive Care Unit of Phramongkutklao Hospital. J Med Assoc Thai 2010; 93: S79 – S83.en_US
dc.identifier.citedreferenceWheeler DS, Giaccone MJ, Hutchinson N, et al. A hospital‐wide quality‐improvement collaborative to reduce catheter‐associated bloodstream infections. Pediatrics 2011; 128: e995 – e1004, quiz e1004‐1007.en_US
dc.identifier.citedreferenceKallen AJ, Patel PR, O'Grady NP. Preventing catheter‐related bloodstream infections outside the intensive care unit: Expanding prevention to new settings. Clin Infect Dis 2010; 51: 335 – 341.en_US
dc.identifier.citedreferenceMarra AR, Cal RG, Durao MS, et al. Impact of a program to prevent central line‐associated bloodstream infection in the zero tolerance era. Am J Infect Control 2010; 38: 434 – 439.en_US
dc.identifier.citedreferenceAdvani S, Reich NG, Sengupta A, et al. Central line‐associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: Extending risk analyses outside the intensive care unit. Clin Infect Dis 2011; 52: 1108 – 1115.en_US
dc.identifier.citedreferenceNiedner MF, Huskins WC, Colantuoni E, et al. Epidemiology of central line‐associated bloodstream infections in the pediatric intensive care unit. Infect Control Hosp Epidemiol 2011; 32: 1200 – 1208.en_US
dc.identifier.citedreferenceEdwards JR, Peterson KD, Mu Y, et al. National Healthcare Safety Network (NHSN) report: Data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009; 37: 783 – 805.en_US
dc.identifier.citedreferenceSimon A, Fleischhack G, Hasan C, et al. Surveillance for nosocomial and central line‐related infections among pediatric hematology–oncology patients. Infect Control Hosp Epidemiol 2000; 21: 592 – 596.en_US
dc.identifier.citedreferenceWurzel CL, Halom K, Feldman JG, et al. Infection rates of Broviac–Hickman catheters and implantable venous devices. Am J Dis Child 1988; 142: 536 – 540.en_US
dc.identifier.citedreferenceFarr BM. Vascular catheter related infections in cancer patients. Surg Oncol Clin N Am 1995; 4: 493 – 503.en_US
dc.identifier.citedreferenceLink H, Bohme A, Cornely OA, et al. Antimicrobial therapy of unexplained fever in neutropenic patients–guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG‐German Cancer Society). Ann Hematol 2003; 82: S105 – S117.en_US
dc.identifier.citedreferenceAbbas AA, Fryer CJ, Paltiel C, et al. Factors influencing central line infections in children with acute lymphoblastic leukemia: Results of a single institutional study. Pediatr Blood Cancer 2004; 42: 325 – 331.en_US
dc.identifier.citedreferenceWylie MC, Graham DA, Potter‐Bynoe G, et al. Risk factors for central line‐associated bloodstream infection in pediatric intensive care units. Infect Control Hosp Epidemiol 2010; 31: 1049 – 1056.en_US
dc.identifier.citedreferenceIngram J, Weitzman S, Greenberg ML, et al. Complications of indwelling venous access lines in the pediatric hematology patient: A prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol 1991; 13: 130 – 136.en_US
dc.identifier.citedreferenceAdler A, Yaniv I, Solter E, et al. Catheter‐associated bloodstream infections in pediatric hematology–oncology patients: Factors associated with catheter removal and recurrence. J Pediatr Hematol Oncol 2006; 28: 23 – 28.en_US
dc.identifier.citedreferenceAdler A, Yaniv I, Steinberg R, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology–oncology patients. J Hosp Infect 2006; 62: 358 – 365.en_US
dc.identifier.citedreferenceCDC. National Vital Statistics; 2009. http://www.cdc.gov/HAI/bsi/bsi.html. Accessed on February 28, 2012.en_US
dc.identifier.citedreferenceScott RD., The Direct Medical Costs of Healthcare‐Associated Infections in U.S. Hospitals and the Benefits of Prevention: CDC. http://www.cdc.gov/ncidod/dhqp/pdf/Scott_CostPaper.pdf; 2009. Accessed on February 28, 2012.en_US
dc.identifier.citedreferenceVernon MO, Hayden MK, Trick WE, et al. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: The effectiveness of source control to reduce the bioburden of vancomycin‐resistant Enterococci. Arch Intern Med 2006; 166: 306 – 312.en_US
dc.identifier.citedreferenceBleasdale SC, Trick WE, Gonzalez IM, et al. Effectiveness of chlorhexidine bathing to reduce catheter‐associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007; 167: 2073 – 2079.en_US
dc.identifier.citedreferencePeterson LR, Singh K. Universal patient disinfection as a tool for infection control: Rub‐a‐dub‐dub, no need for a tub. Arch Intern Med 2006; 166: 274 – 276.en_US
dc.identifier.citedreferenceCDC. Central Line‐Associated Bloodstream Infection (CLABSI): Event Guidelines and Procedures for Monitoring CLABSI. NHSN Manual 2010. http://www.cdc.gov/nhsn/psc_da.html. Accessed on February 28, 2012.en_US
dc.identifier.citedreferenceCDC. Catheter‐Associated Bloodstream Infection Definitions: http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrentpdf 2008. Accessed on February 28, 2012.en_US
dc.identifier.citedreferenceSrinivasan A, Bell WM, Cardo M, et al. Central Line‐Associated Blood Stream Infections—United States, 201, 2008, and 2009. MMWR 2011; 60: 243 – 248.en_US
dc.identifier.citedreferenceCompany WE. Statistical quality control handbook. 1956:OCLC 33858387.en_US
dc.identifier.citedreferenceKelly M, Conway M, Wirth K, et al. Moving CLABSI prevention beyond the intensive care unit: Risk factors in pediatric oncology patients. Infect Control Hosp Epidemiol 2011; 32: 1079 – 1085.en_US
dc.identifier.citedreferenceMiller MR, Niedner MF, Huskins WC, et al. Reducing PICU central line‐associated bloodstream infections: 3‐Year results. Pediatrics 2011; 128: e1077 – 1083.en_US
dc.identifier.citedreferenceMollee P, Jones M, Stackelroth J, et al. Catheter‐associated bloodstream infection incidence and risk factors in adults with cancer: A prospective cohort study. J Hosp Infect 2011; 78: 26 – 30.en_US
dc.identifier.citedreferenceHatakeyama N, Hori T, Yamamoto M, et al. An evaluation of peripherally inserted central venous catheters for children with cancer requiring long‐term venous access. Int J Hematol 2011; 94: 372 – 377.en_US
dc.identifier.citedreferenceValentine KM. Ethanol lock therapy for catheter‐associated blood stream infections in a pediatric intensive care unit. Pediatr Crit Care Med 2011; 12: e292 – e296.en_US
dc.identifier.citedreferenceBlackwood RA, Klein KC, Micel LN, et al. Ethanol locks therapy for resolution of fungal catheter infections. Pediatr Infect Dis J 2011; 30: 1105 – 1107.en_US
dc.identifier.citedreferencehttp://www.childrenshospitals.net/AM/Template.cfm?Section=Collaboratives1& Template=/CM/HTMLDisplay.cfm&ContentID=60780. Accessed on February 28, 2012.en_US
dc.identifier.citedreferenceMermel LA. Prevention of intravascular catheter‐related infections. Ann Intern Med 2000; 132: 391 – 402.en_US
dc.identifier.citedreferencePittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271: 1598 – 1601.en_US
dc.identifier.citedreferenceBerenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter‐related bloodstream infections in the intensive care unit. Crit Care Med 2004; 32: 2014 – 2020.en_US
dc.identifier.citedreferenceSexton JB, Berenholtz SM, Goeschel CA, et al. Assessing and improving safety climate in a large cohort of intensive care units. Crit Care Med 2011; 39: 934 – 939.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.